BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16946100)

  • 1. Delirium induced by clarithromycin in a patient with community-acquired pneumonia.
    Vicente de Vera C; García M; Pifarre Teixido R; Barbe F
    Eur Respir J; 2006 Sep; 28(3):671-2. PubMed ID: 16946100
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarithromycin-induced hypomania in a child - a case report.
    Baranowski WJ
    Acta Psychiatr Scand; 2010 Sep; 122(3):267-8. PubMed ID: 20491717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin monotherapy-induced delirium.
    Ozsoylar G; Sayin A; Bolay H
    J Antimicrob Chemother; 2007 Feb; 59(2):331. PubMed ID: 17208955
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia.
    Lode H; Aronkyto T; Chuchalin AG; Jaaskevi M; Kahnovskii I; Kleutgens K;
    Clin Microbiol Infect; 2004 May; 10(5):403-8. PubMed ID: 15113316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
    Dean NC; Sperry P; Wikler M; Suchyta MS; Hadlock C
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1164-9. PubMed ID: 16569825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
    Ramirez J; Unowsky J; Talbot GH; Zhang H; Townsend L
    Clin Ther; 1999 Jan; 21(1):103-17. PubMed ID: 10090428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Sánchez F; Mensa J; Martínez JA; García E; Marco F; González J; Marcos MA; Soriano A; Torres A
    Clin Infect Dis; 2003 May; 36(10):1239-45. PubMed ID: 12746768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults.
    Sopena N; Martínez-Vázquez C; Rodríguez-Suárez JR; Segura F; Valencia A; Sabrià M
    J Chemother; 2004 Feb; 16(1):102-3. PubMed ID: 15078008
    [No Abstract]   [Full Text] [Related]  

  • 9. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia].
    Iutanova NS
    Antibiot Khimioter; 2004; 49(3):17-21. PubMed ID: 15344392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
    McKinnell J; Tayek JA
    J Clin Rheumatol; 2009 Sep; 15(6):303-5. PubMed ID: 19734738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin-induced delirium in a general hospital.
    Mermelstein HT
    Psychosomatics; 1998; 39(6):540-2. PubMed ID: 9819955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute delirium, probably precipitated by clarithromycin].
    Pijlman AH; Kuck EM; van Puijenbroek EP; Hoekstra JB
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):225-8. PubMed ID: 11219151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin in the management of community-acquired pneumonia.
    McCarty JM
    Clin Ther; 2000 Mar; 22(3):281-94; discussion 265. PubMed ID: 10963284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical end points of therapy for patients with mild community-acquired pneumonia.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S140-4. PubMed ID: 18986280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Community acquired pneumonia].
    Marrie TJ
    Praxis (Bern 1994); 2001 May; 90(21):935-40. PubMed ID: 11512537
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarithromycin-induced thrombocytopenic purpura.
    Oteo JA; Gómez-Cadiñanos RA; Rosel L; Casas JM
    Clin Infect Dis; 1994 Dec; 19(6):1170-1. PubMed ID: 7888564
    [No Abstract]   [Full Text] [Related]  

  • 18. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Dec; (8):1546-57. PubMed ID: 12603953
    [No Abstract]   [Full Text] [Related]  

  • 19. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Jun; (7):1358-68. PubMed ID: 12230751
    [No Abstract]   [Full Text] [Related]  

  • 20. Unforeseen risk in the treatment of severe community-acquired pneumonia with narrow-spectrum antibiotics.
    Folb J; Potter L; Roberts S; Shaw R; Kent W; Vaudrey K
    J Antimicrob Chemother; 2014 Jul; 69(7):2013-4. PubMed ID: 24595803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.